ctrl K

Price Alert

Salarius Pharmaceuticals ... (SLRX)

NASDAQ: SLRX · Real-Time Price · USD

5.76

0.14 (2.49%)

At close: Aug 26, 2025, 3:58 PM

Salarius Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	2.43M	5.9M	12.11M	29.21M
Short-Term Investments	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	1.61M
Other Long-Term Assets	35.41K	66.85K	130.5K	185.99K
Receivables	n/a	n/a	1.61M	n/a
Inventory	n/a	n/a	n/a	n/a
Other Current Assets	265.25K	151.27K	167.58K	172.99K
Total Current Assets	2.99M	6.52M	14.52M	30.16M
Property-Plant & Equipment	n/a	n/a	n/a	7.88K
Goodwill & Intangibles	n/a	n/a	n/a	8.87M
Total Long-Term Assets	35.41K	66.85K	130.5K	10.67M
Total Assets	3.02M	6.59M	14.65M	40.83M
Account Payables	936.99K	602.85K	2.86M	1.54M
Deferred Revenue	n/a	n/a	n/a	n/a
Short-Term Debt	221.87K	289.64K	n/a	n/a
Other Current Liabilities	n/a	n/a	n/a	n/a
Total Current Liabilities	1.51M	1.3M	4.27M	2.11M
Long-Term Debt	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	352.42K	n/a	n/a	n/a
Total Long-Term Liabilities	352.42K	n/a	n/a	n/a
Total Liabilities	1.51M	1.3M	4.27M	2.11M
Total Debt	221.87K	289.64K	n/a	n/a
Common Stock	144.00	393.00	225.00	4.52K
Retained Earnings	-81.92M	-76.35M	-63.81M	-32.2M
Comprehensive Income	n/a	n/a	n/a	n/a
Shareholders Equity	1.51M	5.29M	10.38M	38.72M
Total Investments	n/a	n/a	n/a	1.61M